In April 2020, Byondis, the newly created global pharmaceutical company was created. Byondis have developed proprietary technology solutions that focus on intractable cancers and autoimmune diseases.
The Byondis name was developed by the international Globrands network and fits well with the character of the brand, meets all linguistic, trademark and domain name requirements and was received very positively by all stakeholders.